ArticleTherapeutic advances in gastroenterology2026
Treatment persistence after switching between anti-tumor necrosis factor agents and tofacitinib in ulcerative colitis: A nationwide claims-based cohort study in South Korea.
Ji Eun Baek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.